FGF signalling restricts haematopoietic stem cell specification via modulation of the BMP pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25429520.
- Also identified by DOI 10.1038/ncomms6588 and PMC identifier 4374634.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Haematopoietic stem cells (HSCs) are produced during embryogenesis from the floor of the dorsal aorta. The localization of HSCs is dependent on the presence of instructive signals on the ventral side of the vessel. The nature of the extrinsic molecular signals that control the aortic haematopoietic niche is currently poorly understood. Here we demonstrate a novel requirement for FGF signalling in the specification of aortic haemogenic endothelium. Our results demonstrate that FGF signalling normally acts to repress BMP activity in the subaortic mesenchyme through transcriptional inhibition of bmp4, as well as through activation of two BMP antagonists, noggin2 and gremlin1a. Taken together, these findings demonstrate a key role for FGF signalling in establishment of the developmental HSC niche via its regulation of BMP activity in the subaortic mesenchyme. These results should help inform strategies to recapitulate the development of HSCs in vitro from pluripotent precursors.
Medical subject headings
- Bone Morphogenetic Protein 4
- Carrier Proteins
- Cell Differentiation
- Endothelium, Vascular
- Fibroblast Growth Factors
- Gene Expression Regulation, Developmental
- Hematopoietic Stem Cells
- Zebrafish Proteins